Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis

被引:131
作者
Rule, Simon [1 ]
Dreyling, Martin [2 ]
Goy, Andre [3 ]
Hess, Georg [4 ]
Auer, Rebecca [5 ]
Kahl, Brad [6 ]
Hernandez-Rivas, Jose-Angel [7 ]
Qi, Keqin [8 ]
Deshpande, Sanjay [8 ]
Parisi, Lori [8 ]
Wang, Michael [9 ]
机构
[1] Plymouth Univ, Sch Med, Dept Haematol, Plymouth, Devon, England
[2] LMU, Klinikum Univ Munchen, Dept Med 3, Munich, Germany
[3] Hackensack Univ Med Ctr, Dept Hematol & Oncol, John Theurer Canc Ctr, Hackensack, NJ USA
[4] Johannes Gutenberg Univ Mainz, Univ Med Sch, Dept Hematol Oncol & Pneumol, Mainz, Germany
[5] Barts Canc Inst, Ctr Haematooncol, London, England
[6] Washington Univ, Dept Med, St Louis, MO USA
[7] Univ Complutense, Hosp Univ Infanta Leonor, Dept Hematol, Madrid, Spain
[8] Janssen Res & Dev, Raritan, NJ USA
[9] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
关键词
OPEN-LABEL; RITUXIMAB;
D O I
10.3324/haematol.2018.205229
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E211 / E214
页数:4
相关论文
共 13 条
[1]   Revised response criteria for malignant lymphoma [J].
Cheson, Bruce D. ;
Pfistner, Beate ;
Juweid, Malik E. ;
Gascoyne, Randy D. ;
Specht, Lena ;
Horning, Sandra J. ;
Coiffier, Bertrand ;
Fisher, Richard I. ;
Hagenbeek, Anton ;
Zucca, Emanuele ;
Rosen, Steven T. ;
Stroobants, Sigrid ;
Lister, T. Andrew ;
Hoppe, Richard T. ;
Dreyling, Martin ;
Tobinai, Kensei ;
Vose, Julie M. ;
Connors, Joseph M. ;
Federico, Massimo ;
Diehl, Volker .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :579-586
[2]   Phase II study of bendamustine combined with rituximab in relapsed/refractory mantle cell lymphoma: efficacy, tolerability, and safety findings [J].
Czuczman, Myron S. ;
Goy, A. ;
Lamonica, D. ;
Graf, D. A. ;
Munteanu, M. C. ;
van der Jagt, R. H. .
ANNALS OF HEMATOLOGY, 2015, 94 (12) :2025-2032
[3]  
Dreger P, 2018, BONE MARROW TRANSPLA
[4]  
Dreyling M, 2017, ANN ONCOL, V28, P62, DOI [10.1093/annonc/mdx223, 10.1093/annonc/mdx289]
[5]   Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase study [J].
Dreyling, Martin ;
Jurczak, Wojciech ;
Jerkeman, Mats ;
Silva, Rodrigo Santucci ;
Rusconi, Chiara ;
Trneny, Marek ;
Offner, Fritz ;
Caballero, Dolores ;
Joao, Cristina ;
Witzens-Harig, Mathias ;
Hess, Georg ;
Bence-Bruckler, Isabelle ;
Cho, Seok-Goo ;
Bothos, John ;
Goldberg, Jenna D. ;
Enny, Christopher ;
Traina, Shana ;
Balasubramanian, Sriram ;
Bandyopadhyay, Nibedita ;
Sun, Steven ;
Vermeulen, Jessica ;
Rizo, Aleksandra ;
Rule, Simon .
LANCET, 2016, 387 (10020) :770-778
[6]   TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy [J].
Eskelund, Christian W. ;
Dahl, Christina ;
Hansen, Jakob W. ;
Westman, Maj ;
Kolstad, Arne ;
Pedersen, Lone B. ;
Montano-Almendras, Carmen P. ;
Husby, Simon ;
Freiburghaus, Catja ;
Ek, Sara ;
Pedersen, Anja ;
Niemann, Carsten ;
Raty, Riikka ;
Brown, Peter ;
Geisler, Christian H. ;
Andersen, Mette K. ;
Guldberg, Per ;
Jerkeman, Mats ;
Gronbaek, Kirsten .
BLOOD, 2017, 130 (17) :1903-1910
[7]   Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma [J].
Herrmann, Annina ;
Hoster, Eva ;
Zwingers, Thomas ;
Brittinger, Guenter ;
Engelhard, Marianne ;
Meusers, Peter ;
Reiser, Marcel ;
Forstpointner, Roswitha ;
Metzner, Bernd ;
Peter, Norma ;
Woermann, Bernhard ;
Truemper, Lorenz ;
Pfreundschuh, Michael ;
Einsele, Hermann ;
Hiddemann, Wolfgang ;
Unterhalt, Michael ;
Dreyling, Martin .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (04) :511-518
[8]   Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial [J].
Jerkeman, Mats ;
Eskelund, Christian Winther ;
Hutchings, Martin ;
Raty, Riikka ;
Wader, Karin Fahl ;
Laurell, Anna ;
Toldbod, Helle ;
Pedersen, Lone Bredo ;
Niemann, Carsten Utoft ;
Dahl, Christina ;
Kuitunen, Hanne ;
Geisler, Christian H. ;
Gronbaek, Kirsten ;
Kolstad, Arne .
LANCET HAEMATOLOGY, 2018, 5 (03) :E109-E116
[9]   Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studies [J].
Rule, Simon ;
Dreyling, Martin ;
Goy, Andre ;
Hess, Georg ;
Auer, Rebecca ;
Kahl, Brad ;
Cavazos, Nora ;
Liu, Black ;
Yang, Shiyi ;
Clow, Fong ;
Goldberg, Jenna D. ;
Beaupre, Darrin ;
Vermeulen, Jessica ;
Wildgust, Mark ;
Wang, Michael .
BRITISH JOURNAL OF HAEMATOLOGY, 2017, 179 (03) :430-438
[10]  
Shah BK, 2015, ANTICANCER RES, V35, P3437